Topics Covered

  • Overview of Diffuse Large B-Cell Lymphoma
  • Staging and Grading
  • Current Treatment Options
  • Treatment Options for Resistant Disease
  • Emerging Treatment Approaches
  • The Role of Clinical Trials
  • How Research Contributes to Treatment Choices
  • Tips to Manage Side Effects
  • Questions to Ask Your Health Care Team
  • Quality-of-Life Concerns
  • Questions to Our Panel of Experts

Our Panel of Experts

David J. Straus, MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Continuing Education Credits

(Live Only)

Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.

CancerCare, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.

Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

To request continuing education paperwork, please email your name, profession, and address to connect@cancercare.org after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.

Brochure

You can download the brochure for this workshop(pdf)(80.6 KB)

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.